PCSK9 inhibitors for anti-inflammation in atherosclerosis: protocol for a systematic review and meta-analysis of randomised controlled trials.
BMJ open（2022）
Abstract
CRD42022297710.
MoreTranslated text
Key words
CLINICAL PHARMACOLOGY,Coronary heart disease,Lipid disorders,Protocols & guidelines,VASCULAR MEDICINE
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined